"The Evaluation of Stimulant Withdrawal"

Summary

The purpose of this research study is to determine whether Carvedilol, an FDA approved beta blocker, when administered for an 8-week period to veterans currently undergoing treatment for methamphetamine dependence (1) improves their ability to stay in treatment longer, (2)eases the aversive symptoms that accompany stimulant withdrawal, and (3) increases the time they remain abstinent from methamphetamine.

Timeline

Start

2007-07-01

Primary completion

2010-06-30

Completion

2011-06-30

Drugs

Indications